Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'WELTERMANN A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 22 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laczika, K; Mitterbauer, G; Weltermann, A; Knobl, P; Thalhammer-Scherrer, R; Haas, OA; Lechner, K; Jaeger, U
      Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)

      LEUKEMIA & LYMPHOMA
    2. Stoiser, B; Knobl, P; Fonatsch, C; Haas, OA; Mitterbauer, G; Weltermann, A; Geissler, K; Valent, P; Sperr, W; Pabinger, I; Lechner, K; Jaeger, U
      Prognosis of patients with a second relapse of acute myeloid leukemia

      LEUKEMIA
    3. Kyrle, PA; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Schneider, B; Weltermann, A; Speiser, W; Lechner, K; Eichinger, S
      High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.

      NEW ENGLAND JOURNAL OF MEDICINE
    4. Weltermann, A; Wolzt, M; Petersmann, K; Czerni, C; Graselli, U; Lechner, K; Kyrle, PA
      Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    5. Fiegl, M; Mitterbauer, G; Weltermann, A; Pirc-Danoewinata, H; Jager, U
      Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy

      LEUKEMIA & LYMPHOMA
    6. Meidlinger, P; Knobl, P; Jager, U; Gisslinger, H; Pabinger, I; Weltermann, A; Lechner, K; Geissler, K
      Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment

      ANNALS OF HEMATOLOGY
    7. Agis, H; Weltermann, A; Mitterbauer, G; Thalhammer, R; Edelhauser, M; Seewann, HL; Valent, P; Lechner, K; Fonatsch, C; Geissler, K
      Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia

      ANNALS OF HEMATOLOGY
    8. Fiegl, M; Weltermann, A; Stindl, R; Fonatsch, C; Lechner, K; Gisslinger, H
      Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature

      ANNALS OF HEMATOLOGY
    9. Eichinger, S; Weltermann, A; Philipp, K; Hafner, E; Kaider, A; Kittl, EM; Brenner, B; Mannhalter, C; Lechner, K; Kyrle, PA
      Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden

      THROMBOSIS AND HAEMOSTASIS
    10. Fureder, W; Weltermann, A; Chott, A; Gisslinger, H; Valent, P; Jager, U; Geissler, K; Lechner, K
      Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine)

      WIENER KLINISCHE WOCHENSCHRIFT
    11. KYRLE PA; MANNHALTER C; BEGUIN S; STUMPFLEN A; HIRSCHL M; WELTERMANN A; STAIN M; BRENNER B; SPEISER W; PABINGER I; LECHNER K; EICHINGER S
      CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE

      Arteriosclerosis, thrombosis, and vascular biology
    12. WELTERMANN A; EICHINGER S; KYRLE PA
      A NOVEL IMMUNOASSAY FOR THE QUANTIFICATION OF HUMAN TISSUE FACTOR-BINDING TO ACTIVATED FACTOR-VII

      Blood coagulation & fibrinolysis
    13. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    14. WELTERMANN A; MITTERBAUER GJ; MITTERBAUER M; HATTEY E; SPEISER W; GISSLINGER H; KNOBL P; EICHINGER S
      DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)

      Wiener Klinische Wochenschrift
    15. KYRLE PA; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; SPEISER W; WELTERMANN A; KAIDER A; PABINGER I; LECHNER K; EICHINGER S
      LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    16. WOLZT M; EDER M; WELTERMANN A; ENTLICHER J; EICHLER HG; KYRLE PA
      COMPARISON OF THE EFFECTS OF DIFFERENT LOW-MOLECULAR-WEIGHT HEPARINS ON THE HEMOSTATIC SYSTEM ACTIVATION IN-VIVO IN MAN

      Thrombosis and haemostasis
    17. KYRLE PA; EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; SCHNEIDER B; MANNHALTER C; MELICHART M; TRAXLER G; WELTERMANN A; SPEISER W; LECHNER K
      PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    18. KYRLE PA; BROCKMEIER J; WELTERMANN A; EICHINGER S; SPEISER W; LECHNER K; EICHLER HG
      INHIBITION RATHER THAN ENHANCEMENT OF HEMOSTATIC SYSTEM ACTIVATION DURING INITIATION OF ORAL ANTICOAGULANT TREATMENT

      Thrombosis and haemostasis
    19. WELTERMANN A; KYRLE PA; EICHINGER S
      QUANTIFICATION OF HUMAN TISSUE FACTOR (TF) BINDING TO RECOMBINANT FACTOR VIIA (RVIIA)

      Thrombosis and haemostasis
    20. EICHINGER S; BRENNER B; PHILIPP K; PUTZ M; SCHUCHTER K; BAUER K; KITTL E; KAIDER A; WELTERMANN A; LECHNER K; KYRLE PA
      MARKED COAGULATION ACTIVATION DURING PREGNANCY WITHOUT EVIDENCE OF VENOUS THROMBOEMBOLISM (VTE)

      Thrombosis and haemostasis
    21. WELTERMANN A; KYRLE PA
      LABORATORY STUDIES ON THE RELIABILITY OF A COMMERCIAL IMMUNOASSAY FORTHROMBIN-ANTITHROMBIN COMPLEXES

      Blood coagulation & fibrinolysis
    22. WOLZT M; WELTERMANN A; NIESZPAURLOS M; SCHNEIDER B; FASSOLT A; LECHNER K; EICHLER HG; KYRLE PA
      STUDIES ON THE NEUTRALIZING EFFECTS OF PROTAMINE ON UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN(R)) AT THE SITE OF ACTIVATION OF THE COAGULATION SYSTEM IN MAN

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 03:25:46